A medical review of MSC clinical trials 2026: key evidence from ISCT Dublin, a Japanese phase III synovial-MSC meniscal repair trial, bone marrow vs cord tissue OA data, and mitochondrial EV mechanisms.
A 2025 clinical trial reports the first-ever strength improvement in ALS patients using intranasally delivered MSC exosomes — zero adverse events across 32 treatments.
Diabetic wounds that refuse to heal affect hundreds of thousands of Thais. Discover how exosome therapy and MSC treatment are giving patients a real path to recovery.
MSC-derived exosomes are reshaping regenerative medicine — learn how these nano-sized vesicles deliver therapy without the risks of whole-cell transplantation.
Exosomes are tiny, membrane-bound vesicles released by cells into the extracellular environment. These microscopic structures, typically ranging from 30 to 150 nanometers in diameter, play a crucial role in intercellular communication. Once thought to be mere cellular waste, exosomes are now recognized as sophisticated messengers that carry a diverse cargo of...
Russian 
English 
Chinese 
French